Back to News
Market Impact: 0.25

Detailed Fundamental Analysis

IWDNDAQ
Company FundamentalsAnalyst InsightsHealthcare & Biotech
Detailed Fundamental Analysis

Validea's fundamental report on the iShares Russell 1000 Value ETF (IWD) identifies it as a Large-Cap Low Volatility ETF, primarily concentrated in the Financial sector and Biotechnology & Drugs industry. The analysis highlights IWD's strong exposure to Low Volatility (score of 81) and moderate exposure to Value (65) and Quality (51), while exhibiting low Momentum (30). This detailed factor breakdown offers institutional investors a clear understanding of IWD's underlying factor tilts and sector allocations for portfolio construction and risk assessment.

Analysis

The Validea fundamental report on the iShares Russell 1000 Value ETF (IWD) provides a clear quantitative breakdown of its factor exposures. The ETF is characterized by a strong orientation towards Low Volatility, registering a score of 81 out of 99, which aligns with its classification as a Large-Cap Low Volatility fund. Its exposure to the Value factor is moderate at a score of 65, while its Quality score is neutral at 51. A key characteristic is its minimal exposure to Momentum, indicated by a low score of 30. The portfolio's composition shows a significant concentration in the Financial sector, with the Biotechnology & Drugs industry being the largest single industry holding. This factor profile suggests IWD is constructed to prioritize stability and valuation over capturing current market trends, making it a defensive holding rather than a growth-oriented one.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

IWD0.00
NDAQ0.00

Key Decisions for Investors

  • Investors seeking defensive exposure to U.S. large-caps should consider IWD, given its high Low Volatility score of 81 and moderate Value score of 65.
  • The ETF's very low Momentum score of 30 indicates it is likely to lag during strong, momentum-led market rallies, a key consideration for growth-focused investors.
  • Portfolio managers must account for IWD's significant concentration in the Financials and Biotechnology & Drugs sectors to manage overall portfolio diversification and sector-specific risk.
  • Despite its name, IWD should be primarily viewed as a low-volatility fund with a value tilt, not a deep value strategy, making it suitable for capital preservation objectives.